ST Pharm Statistics

Total Valuation

ST Pharm has a market cap or net worth of KRW 1.67 trillion. The enterprise value is 1.69 trillion.

Market Cap	1.67T
Enterprise Value	1.69T

Important Dates

The last earnings date was Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

ST Pharm has 20.15 million shares outstanding. The number of shares has increased by 1.91% in one year.

Current Share Class	n/a
Shares Outstanding	20.15M
Shares Change (YoY)	+1.91%
Shares Change (QoQ)	-0.74%
Owned by Insiders (%)	7.81%
Owned by Institutions (%)	12.48%
Float	12.38M

Valuation Ratios

The trailing PE ratio is 49.00 and the forward PE ratio is 43.08. ST Pharm's PEG ratio is 0.74.

PE Ratio	49.00
Forward PE	43.08
PS Ratio	5.70
PB Ratio	3.41
P/TBV Ratio	3.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	0.74

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.75, with an EV/FCF ratio of -480.23.

EV / Earnings	52.17
EV / Sales	6.06
EV / EBITDA	32.75
EV / EBIT	63.90
EV / FCF	-480.23

Financial Position

The company has a current ratio of 4.00, with a Debt / Equity ratio of 0.25.

Current Ratio	4.00
Quick Ratio	1.87
Debt / Equity	0.25
Debt / EBITDA	2.36
Debt / FCF	-34.55
Interest Coverage	4.33

Financial Efficiency

Return on equity (ROE) is 6.94% and return on invested capital (ROIC) is 2.78%.

Return on Equity (ROE)	6.94%
Return on Assets (ROA)	2.47%
Return on Invested Capital (ROIC)	2.78%
Return on Capital Employed (ROCE)	4.33%
Revenue Per Employee	425.41M
Profits Per Employee	49.45M
Employee Count	655
Asset Turnover	0.42
Inventory Turnover	1.20

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.64% in the last 52 weeks. The beta is 0.56, so ST Pharm's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	+31.64%
50-Day Moving Average	86,616.00
200-Day Moving Average	93,568.00
Relative Strength Index (RSI)	43.92
Average Volume (20 Days)	190,565

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ST Pharm had revenue of KRW 278.64 billion and earned 32.39 billion in profits. Earnings per share was 1,689.86.

Revenue	278.64B
Gross Profit	94.05B
Operating Income	26.44B
Pretax Income	36.69B
Net Income	32.39B
EBITDA	51.59B
EBIT	26.44B
Earnings Per Share (EPS)	1,689.86

Full Income Statement

Balance Sheet

The company has 100.96 billion in cash and 121.58 billion in debt, giving a net cash position of -20.62 billion or -1,022.98 per share.

Cash & Cash Equivalents	100.96B
Total Debt	121.58B
Net Cash	-20.62B
Net Cash Per Share	-1,022.98
Equity (Book Value)	488.52B
Book Value Per Share	24,275.09
Working Capital	242.55B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 53.12 billion and capital expenditures -56.64 billion, giving a free cash flow of -3.52 billion.

Operating Cash Flow	53.12B
Capital Expenditures	-56.64B
Free Cash Flow	-3.52B
FCF Per Share	-174.59

Full Cash Flow Statement

Margins

Gross margin is 33.75%, with operating and profit margins of 9.49% and 11.62%.

Gross Margin	33.75%
Operating Margin	9.49%
Pretax Margin	13.17%
Profit Margin	11.62%
EBITDA Margin	18.51%
EBIT Margin	9.49%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 500.00, which amounts to a dividend yield of 0.60%.

Dividend Per Share	500.00
Dividend Yield	0.60%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	29.04%
Buyback Yield	-1.91%
Shareholder Yield	-1.30%
Earnings Yield	1.94%
FCF Yield	-0.21%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ST Pharm has an Altman Z-Score of 5.85.

Altman Z-Score	5.85
Piotroski F-Score	n/a